Answers are grounded in this paper and cite their sources.
Evaluates efficacy of ultralong-acting neuromuscular blocking agents, suggesting safer reversal options.
. The two agents thus form a promising partnership featuring ultralong-acting blockade and on-demand reversal.
No takes yet. Share an insight, caveat, or question.
Gan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: